Stock-Based Compensation
$349.00M
TTM · Period ending: · USD
MRNA Stock-Based Compensation
Latest reported$349.00Mperiod ending
Latest reported$349.00Mperiod ending
MRNA TTM Stock-Based Comp ($40.06M → $349.00M)
TTM stock-based compensation
High-resolution chart · PNG
MRNA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 349,000,000 | |
| 359,000,000 | |
| 370,000,000 | |
| 474,000,000 | |
| 461,000,000 | |
| 443,000,000 | |
| 429,000,000 | |
| 404,000,000 | |
| 369,000,000 | |
| 331,000,000 | |
| 305,000,000 | |
| 288,000,000 | |
| 281,000,000 | |
| 257,000,000 | |
| 226,000,000 | |
| 201,000,000 | |
| 171,000,000 | |
| 156,000,000 | |
| 142,000,000 | |
| 130,479,000 | |
| 113,685,000 | |
| 103,685,000 | |
| 93,685,000 | |
| 88,532,000 | |
| 86,130,000 | |
| 82,625,000 | |
| 81,122,000 | |
| 92,437,000 | |
| 86,353,000 | |
| 79,211,000 | |
| 72,565,000 | |
| 51,952,000 | |
| 47,597,000 | |
| 42,575,000 | |
| 40,055,000 |